Richard R Harris

Title: The Innovations of Richard R. Harris

Introduction

Richard R. Harris is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive agents. With a total of 3 patents, his work has had a profound impact on the treatment of various autoimmune diseases.

Latest Patents

Harris's latest patents include innovative compounds such as 4-Quinoline carboxylic acid derivatives. These compounds are recognized for their usefulness as immunomodulatory and anti-inflammatory agents. One of his notable inventions is the 2-(2'-fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid, which is effective in treating autoimmune diseases, organ transplantation rejection, graft vs. host disease, multiple sclerosis, and chronic inflammatory diseases like rheumatoid arthritis. Additionally, he has developed phenylquinolinecarboxylic acids that are beneficial for treating skin and muco-epithelial diseases.

Career Highlights

Richard R. Harris is currently employed at E.I. du Pont de Nemours and Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that improve the quality of life for patients suffering from chronic conditions.

Collaborations

Harris has collaborated with esteemed colleagues such as Neil R. Ackerman and Scott E. Loveless, contributing to a dynamic research environment that fosters innovation.

Conclusion

Richard R. Harris exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations have paved the way for advancements in the treatment of serious health conditions.